About: therapy-related acute myeloid leukemia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: therapy-related acute myeloid leukemia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
ICD-10	wds:Q53948161-73781A30-6516-44FE-9D2C-084BF5970538
ICD-10	C92.0
rdfs:label	therapy-related acute myeloid leukemia (en)
skos:prefLabel	therapy-related acute myeloid leukemia (en)
name	therapy-related acute myeloid leukemia (en)
instance of	wds:Q53948161-94efedd2-4af9-a84c-a7bb-dd0444898eac
instance of	disease
subclass of	wds:Q53948161-a2a070f8-46af-7060-682b-07d3290e8356
subclass of	acute myeloid leukemia
NCI Thesaurus ID	wds:Q53948161-2ad0d5bd-4277-f619-a378-02f1426c5ba4 wds:Q53948161-861F9AED-76D4-4680-87C2-C6B5A14B8882
UMLS CUI	wds:Q53948161-8cd7a22d-442d-6275-cf62-92a01269d068
ICD-11 ID (MMS)	wds:Q53948161-af28b528-42ab-419a-b9bf-42807e51b220
ICD-11 (foundation)	wds:Q53948161-14A901F4-01D4-4E63-866D-4496FBC90D3B
NCI Thesaurus ID	C27912 C8252
UMLS CUI	C1336735
ICD-11 ID (MMS)	XH4EJ0
ICD-11 (foundation)	952132780
ICD-O	wds:Q53948161-269F28B9-A020-4FF1-9E46-4108FB3F2AA5
ICD-O	9920/3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q53948161
is main subject of	Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. The DNA double-strand break response is abnormal in myeloblasts from patients with therapy-related acute myeloid leukemia. Therapy-related acute myeloid leukemia with favorable cytogenetics: still favorable? Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia. Prognosis in therapy-related acute myeloid leukemia and impact of karyotype Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: From the bedside to the target genes Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome. Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). A new case of translocation t(6;11)(q21;q23) in a therapy-related acute myeloid leukemia resulting in an MLL-AF6q21 fusion. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25) Therapy related acute myeloid leukemia with t(10:16): a rare entity Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia Quantitative RT-PCR analysis of the MOZ-CBP fusion transcript in therapy-related acute myeloid leukemia with t(8;16)(p11;p13). Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group The leucine twenty homeobox (LEUTX) gene, which lacks a histone acetyltransferase domain, is fused to KAT6A in therapy-related acute myeloid leukemia with t(8;19)(p11;q13). Preexisting TP53 mutation in therapy-related acute myeloid leukemia Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes A complex t(1;22;11)(q44;q13;q23) translocation causing MLL-p300 fusion gene in therapy-related acute myeloid leukemia Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations. High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases Therapy-related acute myeloid leukemia with 11q23 abnormality coexisting with refractory metastatic Ewing sarcoma: report of a case and review of the literature Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. Circulating Breast Carcinoma Cells Mimicking Therapy-Related Acute Myeloid Leukemia Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutation Therapy-related acute myeloid leukemia in Crohn's disease Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene Translocation (X;10) in a child with therapy-related acute myeloid leukemia following chemotherapy for Ewing's Sarcoma. Therapy-related Acute Myeloid Leukemia Following Treatment for Burkitt's Lymphoma Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome Therapy Related Acute Myeloid Leukemia with t(8;16) Mimicking Acute Promyelocytic Leukemia Translocation t(7;11)(P15;P15) in a patient with therapy-related acute myeloid leukemia following bimolane and ICRF-154 treatment for psoriasis Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia Therapy-related acute myeloid leukemia with t(9;11)(p12;q23) in a patient treated for acute promyelocytic leukemia Therapy-related acute myeloid leukemia with t(10;11)(q23;p15) following successful chemotherapy for acute promyelocytic leukemia with t(15;17)(q22;q21) Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features Therapy-related acute myeloid leukemia with t(2;11)(q37;q23) after treatment for osteosarcoma. BRCA2-associated therapy-related acute myeloid leukemia Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study Novel Therapeutics for Therapy-Related Acute Myeloid Leukemia: 2014. Epistaxis and severe weakness in a patient with multiple myeloma. Therapy-related acute myeloid leukemia, pure erythroid leukemia Therapy-related myelodysplastic syndrome with trisomy 1q due to der(1;7) and megakaryoblastic proliferation developing during complete remission of therapy-related acute myeloid leukemia with t(8;21) Therapy related acute myeloid leukemia after exposure to 5-fluorouracil: a case report Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literature Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European [Chidamide combined with chemotherapy for treatment of therapy-related acute myeloid leukemia secondary to peripheral T-cell lymphoma: a case report and literatures review] Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia Therapy-related acute myeloid leukemia following HIV-associated lymphoma Therapy-related acute myeloid leukemia after chemotherapy in extensive disease-small cell lung cancer Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype Simultaneous occurrence of BCR/ABL1 and RUNX1/RUNX1T1 in a case of therapy-related acute myeloid leukemia Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab-bendamustine The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software